UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                    Form 10-Q


(Mark one)

[X]  Quarterly  Report Under Section 13 or 15(d) of The Securities  Exchange Act
     of 1934

For the quarterly period ended September 30, 2008


[_]  Transition Report Under Section 13 or 15(d) of The Securities  Exchange Act
     of 1934

For the transition period from ______________ to _____________


Commission file number 000-26703


                     MEDICAL MAKEOVER CORPORATION OF AMERICA
         ---------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


   Delaware                           000-11596            65-0907798
----------------------------        ------------         -------------------
(State or other jurisdiction        (Commission         (IRS Employer
 of incorporation)                   file number)        Identification No.)


                     500 Australian Avenue South, Suite 620
                             West Palm Beach FL33401
           -----------------------------------------------------------
               (Address of principal executive offices)(Zip Code)


Registrant's telephone number, including area code: (561) 951-1398


                                       N/A
          -------------------------------------------------------------
          (Former name or former address, if changes since last report)





<PAGE>


Indicate by check mark whether the issuer (1) has filed all reports  required to
be filed by  Section  13 or 15(d) of the  Securities  Exchange  Act  during  the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports),  and (2) has been subject to such filing requirements for
the past 90 days. Yes |X| No |_|.


Indicate  by check mark  whether  the  registrant  is an  accelerated  filer,  a
non-accelerated filer, or a smaller reporting company.

         Large accelerated filer |_|        Accelerated filer |_|
         Non-accelerated filer  |_|         Smaller reporting company  |X|


Indicate by check mark whether the  registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act).         |X| Yes          |_| No


                      APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date:


As of October  31,  2008,  there were  approximately  108,119,318  shares of the
Issuer's common stock, par value $0.0001 per share outstanding.


              CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain  statements in this quarterly report on Form 10-Q contain or may contain
forward-looking  statements  that  are  subject  to  known  and  unknown  risks,
uncertainties  and other factors which may cause actual results,  performance or
achievements to be materially different from any future results,  performance or
achievements  expressed  or implied by such  forward-looking  statements.  These
forward-looking  statements  were  based on  various  factors  and were  derived
utilizing  numerous  assumptions  and other  factors that could cause our actual
results to differ materially from those in the forward-looking statements. These
factors  include,  but  are not  limited  to,  economic,  political  and  market
conditions and fluctuations,  government and industry regulation,  interest rate
risk, U.S. and global competition,  and other factors including the risk factors
set forth in our Form  10-KSB.  Most of these  factors are  difficult to predict
accurately and are generally  beyond our control.  You should consider the areas
of risk described in connection with any forward-looking  statements that may be
made  herein.  Readers  are  cautioned  not to  place  undue  reliance  on these
forward-looking  statements,  which  speak  only as of the date of this  report.
Readers should carefully review this quarterly report in its entirety, including
but not limited to our financial  statements and the notes  thereto.  Except for
our ongoing  obligations  to  disclose  material  information  under the Federal
securities laws, we undertake no obligation to release publicly any revisions to
any forward-looking  statements, to report events or to report the occurrence of
unanticipated  events.  For  any  forward-looking  statements  contained  in any
document,  we claim  the  protection  of the  safe  harbor  for  forward-looking
statements contained in the Private Securities Litigation Reform Act of 1995.




<PAGE>



INDEX

                         PART I. - FINANCIAL INFORMATION

ITEM 1.    Financial Statements                                                4

Balance Sheet................................................................F-4
Statements of Operations.....................................................F-5
Statements of Stockholders' Equity...........................................F-6
Statements of Cash Flows.....................................................F-7
Notes to Financial Statement.................................................F-8

ITEM 2.    Management's Discussion and Analysis or Plan of Operations         10

ITEM 3.    Quantitative and Qualitative Disclosures About Market Risk         12

ITEM 4T.   Controls and Procedures                                            13

                          PART II. - OTHER INFORMATION

ITEM 1.    Legal Proceedings                                                  13

ITEM 1A.   Risk Factors                                                       13

ITEM 2.    Unregistered Sales of Equity Securities and Use of Proceeds        13

ITEM 3.    Defaults Upon Senior Securities                                    13

ITEM 4.    Submission of Matters to a Vote of Security Holders                13

ITEM 5.    Other Information                                                  13

ITEM 6.    Exhibits and Reports                                               14

SIGNATURES                                                                    14







<PAGE>


                         PART I. - FINANCIAL INFORMATION

ITEM 1. Financial Statements


<TABLE>
<CAPTION>
                     Medical Makeover Corporation of America
                        (a development stage enterprise)
                                  Balance Sheet

                                                                    September     December
                                                                    30, 2008      31, 2007
                                                                  ------------- ------------
                                                                   (Unaudited)
<S>                                                               <C>           <C>
                                     ASSETS
CURRENT ASSETS
  Cash                                                            $           0 $          0
  Accounts receivable                                                         0            0
                                                                  ------------- ------------

          Total current assets                                                0            0
                                                                  ------------- ------------

OTHER ASSETS
   Mining claim interest                                                      0            0
                                                                  ------------- ------------
          Total other assets                                                  0            0
                                                                  ------------- ------------
Total Assets                                                      $           0 $          0
                                                                  ============= ============

                      LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES

     Accounts payable and accrued liabilities                     $     237,597 $    183,097
     Stockholder loans and accrued interest                              20,459       46,681
     Note payable                                                       145,141      164,572
                                                                  ------------- ------------
          Total current liabilities                                     403,197      394,350
                                                                  ------------- ------------
Total Liabilities                                                       403,197      394,350
                                                                  ------------- ------------

STOCKHOLDERS' EQUITY
  Preferred stock, $0.0001 par value, 10,000,000 shares
       authorized, 0 issued and outstanding                                   0            0
  Common stock, $0.0001 par value, authorized 200,000,000 shares;
      108,119,318 and 77,393,592 issued and outstanding                  10,812        7,739
  Additional paid-in capital                                          1,048,813      996,938
  Deficit accumulated during the development stage                   (1,462,822)  (1,399,027)
                                                                  ------------- ------------

          Total stockholders' equity                                   (403,197)    (394,350)
                                                                  ------------- ------------
Total Liabilities and  Stockholders' Equity                       $           0 $          0
                                                                  ============= ============
</TABLE>


     The accompanying notes are an integral part of the financial statements


                                       F-4

<PAGE>


<TABLE>
<CAPTION>
                     Medical Makeover Corporation of America
                        (a development stage enterprise)
                            Statements of Operations
                         Nine Months Ended September 30,
                                   (unaudited)


                                                                                                              From March
                                                                                                                29, 1999
                                                  Three Months                         Nine Months             (Inception)
                                       -------------------------------    ------------------------------       to Sep 30,
                                            2008             2007              2008            2007               2008
                                       --------------   --------------    --------------  --------------    ----------------

<S>                                    <C>              <C>               <C>             <C>               <C>
REVENUES                               $            0   $            0    $            0  $            0    $         44,413
                                       --------------   --------------    --------------  --------------    ----------------

OPERATING EXPENSES
   General and administrative                  10,000           10,000            30,000          30,000           1,221,986
   Professional fees                           11,500            6,500            24,500          13,000             251,448
                                       --------------   --------------    --------------  --------------    ----------------

          Net operating loss                   21,500           16,500            54,500          43,000           1,473,434
                                       --------------   --------------    --------------  --------------    ----------------

   Interest expense                             2,729            4,297             9,295          10,153              33,801
                                       --------------   --------------    --------------  --------------    ----------------


Net loss                               $      (24,229)  $      (20,797)   $      (63,795) $      (53,153)   $     (1,462,822)
                                       ==============   ==============    ==============  ==============    ================

Basic net loss per share               $        (0.00)  $        (0.01)   $        (0.01) $        (0.01)
                                       ==============   ==============    ==============  ==============

Weighted average shares outstanding        89,320,584       66,389,895        82,225,283      66,389,895
                                       ==============   ==============    ==============  ==============
</TABLE>







     The accompanying notes are an integral part of the financial statements


                                       F-5

<PAGE>


<TABLE>
<CAPTION>
                     Medical Makeover Corporation of America
                        (a development stage enterprise)
                   Statement of Stockholders' Equity (Deficit)



                                                                                                Deficit
                                                                                              Accumulated
                                                                               Additional      During the         Total
                                                      Number of     Common       Paid-in      Development     Stockholders'
                                                       Shares        Stock       Capital         Stage           Equity
                                                     ------------ ----------- ------------- ---------------- ---------------

<S>                        <C>                         <C>        <C>         <C>           <C>              <C>
BEGINNING BALANCE, January 1, 2005                     46,996,876 $     4,700 $     460,400 $       (562,336)$       (97,236)

Shares issued for services                              4,595,505         459       257,203                0         257,662
Net loss                                                        0           0             0         (693,568)       (693,568)
                                                     ------------ ----------- ------------- ---------------- ---------------

BALANCE, December 31, 2005                             51,592,381       5,159       717,603       (1,255,904)       (533,142)
Shares issued for services                                300,000          30        16,470                0          16,500
Shares issued to settle debt and  interest expense     13,205,800       1,321       231,284                0         232,605
Net loss                                                        0           0             0          (69,104)        (69,104)
                                                     ------------ ----------- ------------- ---------------- ---------------

BALANCE, December 31, 2006                             65,098,181       6,510       965,357       (1,325,008)       (353,141)
Shares issued to settle debt and  interest expense     12,294,411       1,229        31,581                0          32,810

Net loss                                                        0           0             0          (78,730)        (78,730)
                                                     ------------ ----------- ------------- ---------------- ---------------

BALANCE, December 31, 2007                             77,392,592       7,739       996,938       (1,399,027)       (394,350)
Shares issued to settle debt and  interest expense     30,726,726       3,073        51,875                0          54,948
Net loss                                                        0           0             0          (63,795)        (63,795)
                                                     ------------ ----------- ------------- ---------------- ---------------
ENDING BALANCE, September 30, 2008 (unaudited)        108,119,318 $    10,812 $   1,048,813 $     (1,462,822)$      (403,197)
                                                     ============ =========== ============= ================ ===============
</TABLE>









     The accompanying notes are an integral part of the financial statements


                                       F-6

<PAGE>



<TABLE>
<CAPTION>
                     Medical Makeover Corporation of America
                        (a development stage enterprise)
                            Statements of Cash Flows
                         Nine Months Ended September 30,
                                   (Unaudited)


                                                                                                      From March
                                                                                                       29, 1999
                                                                                                   (Inception) to
                                                                   2008              2007           Sept 30, 2008
                                                               --------------   ---------------   ----------------
<S>                                                            <C>              <C>               <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss                                                       $      (63,795)  $       (53,153)  $     (1,462,822)
Adjustments to reconcile net loss to net cash used by
 operating activities:
    Stock issued for services                                               0                 0            440,422
    Depreciation                                                            0                 0              3,445
Changes in operating assets and liabilities
    Increase (decrease) in accounts payable & acc'd expenses           54,500            43,000            237,597
    Increase (decrease) in accrued interest expense                     9,295            10,153             24,340
                                                               --------------   ---------------   ----------------

Net cash provided (used) by operating activities                            0                 0           (757,018)
                                                               --------------   ---------------   ----------------

CASH FLOWS FROM INVESTING ACTIVITIES:
 Purchase of fixed assets                                                   0                 0            (20,671)
                                                               --------------   ---------------   ----------------

Net cash provided (used) by investing activities                            0                 0            (20,671)
                                                               --------------   ---------------   ----------------

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock for cash                             0                 0            315,000
Proceeds from stockholder loan payable                                      0                 0             78,189
Payments on stockholder loans                                               0                 0            (35,500)
Proceeds from third party notes payable                                     0                 0            420,000
                                                               --------------   ---------------   ----------------

Net cash provided by financing activities                                   0                 0            777,689
                                                               --------------   ---------------   ----------------

Net increase (decrease) in cash                                             0                 0                  0
                                                               --------------   ---------------   ----------------

CASH, beginning of period                                                   0                 0                  0
                                                               --------------   ---------------   ----------------

CASH, end of period                                            $            0   $             0   $              0
                                                               ==============   ===============   ================
SUPPLEMENTAL DISCLOSURE OF CASH FLOW
INFORMATION:
Non-Cash Financing Activities:
   Common stock issued for reduction in notes payable and
           accrued interest                                    $       54,948   $        18,486
                                                               ==============   ===============
</TABLE>




     The accompanying notes are an integral part of the financial statements

                                       F-7

<PAGE>



                     Medical Makeover Corporation of America
                        (a development stage enterprise)
                          NOTES TO FINANCIAL STATEMENTS
                   (Information with regard to the nine months ended
                    September 30, 2008 and 2007 is unaudited)


Note 1 -  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

(a) The Company Medical Makeover  Corporation of America is a Delaware chartered
development  stage  corporation which conducts business from its headquarters in
West Palm Beach, Florida. It was formed on March 29, 1999.

         The following summarize the more significant accounting and reporting
policies and practices of the Company:

(b) Use of estimates The financial  statements  have been prepared in conformity
with  generally  accepted  accounting  principles.  In preparing  the  financial
statements, management is required to make estimates and assumptions that affect
the reported  amounts of assets and liabilities as of the date of the statements
of financial condition and revenues and expenses for the year then ended. Actual
results may differ significantly from those estimates.

(c) Start-up costs Costs of start-up activities,  including  organization costs,
are expensed as incurred, in accordance with Statement of Position (SOP) 98-5.

(d) Stock  compensation  for  services  rendered The Company may issue shares of
common stock in exchange for  services  rendered.  The costs of the services are
valued  according  to generally  accepted  accounting  principles  and have been
charged to operations.

(e) Net income (loss) per share Basic loss per share is computed by dividing the
net income (loss) by the weighted  average  number of common shares  outstanding
during the period.

(f) Property and  equipment  All property and equipment are recorded at cost and
depreciated over their estimated useful lives,  using the straight-line  method.
Upon sale or  retirement,  the cost and  related  accumulated  depreciation  are
eliminated  from their  respective  accounts,  and the resulting gain or loss is
included in the results of operations. Repairs and maintenance charges, which do
not  increase  the useful  lives of the  assets,  are charged to  operations  as
incurred.

(g) Interim financial  information The financial  statements for the nine months
ended  September  30, 2008 and 2007 are  unaudited  and include all  adjustments
which in the opinion of management are necessary for fair presentation, and such
adjustments  are of a normal and  recurring  nature.  The  results  for the nine
months are not indicative of a full year results.


NOTE 2 - GOING CONCERN

The  accompanying  financial  statements  have been  prepared  assuming that the
Company will continue as a going concern.  The Company's  financial position and
operating  results  raise  substantial  doubt  about the  Company's  ability  to
continue  as a  going  concern,  as  reflected  by the net  loss  of  $1,463,037
accumulated  through  September 30, 2008. The ability of the Company to continue
as a going concern is dependent upon commencing operations, developing sales and
obtaining  additional  capital and  financing.  The financial  statements do not
include  any  adjustments  that might be  necessary  if the Company is unable to
continue as a going concern. The Company is currently seeking additional capital
to allow it to begin its planned operations





                                       F-8

<PAGE>


                     Medical Makeover Corporation of America
                        (a development stage enterprise)
                          NOTES TO FINANCIAL STATEMENTS


NOTE 3 - NOTES PAYABLE

In December 2004, the Company received $20,000 and $115,000 in the first quarter
2005, in cash as a short-term  loan. This loan matures in six months and carries
a 8% interest  rate. In June 2005, the Company  received a $250,000  convertible
loan from a third party. This loan matures in six months and is in default,  and
carries a 8% interest rate.


NOTE 4 - CASH AND CASH EQUIVALENTS

For purposes of the  statement of cash flows,  the Company  considers all highly
liquid  investments  with maturity of three months or less when  purchased to be
cash equivalents


NOTE 5 - USE OF ESTIMATES

The  financial  statements  have been  prepared in  conformity  with  accounting
principles  generally  accepted in the United States. In preparing the financial
statements, management is required to make estimates and assumptions that affect
the reported  amounts of assets and liabilities as of the date of the statements
of financial condition and revenues and expenses for the year then ended. Actual
results may differ significantly from those estimates.


NOTE 6 - NON-CASH TRANSACTIONS

In the second  quarter of 2008, the Company  issued  7,516,269  shares of common
stock to settle  $14,000 of  convertible  debt and  $3,304 of  accrued  interest
thereon at an average price per share of $0.0023.. In the third quarter of 2008,
the  Company  issued  30,726,726  shares of common  stock to settle  $35,450  of
convertible  debt and $2,194 of accrued interest thereon at an average price per
share of $0.0012.












                                       F-9

<PAGE>



ITEM 2. Management's  Discussion and Analysis of Financial Condition and Results
        of Operations

     The following  discussion and analysis  should be read in conjunction  with
our Financial Statements and Notes thereto appearing elsewhere in this Report on
Form 10-Q as well as our other SEC filings.

Overview

     The Company is a  development  stage  company and has not yet  generated or
realized  any  revenues  from  business  operations  since 2005.  The  Company's
business  strategy changed in the third quarter 2007 to seeking potential merger
candidates.  The Company's  auditors have issued a going concern  opinion in our
audited  financial  statements for the fiscal year ended December 31, 2007. This
means that our auditors  believe there is doubt that the Company can continue as
an on-going  business for the next twelve  months  unless it obtains  additional
capital to pay its bills.  This is because  the Company  has not  generated  any
revenues and no revenues are currently anticipated.  Accordingly,  we must raise
cash from  sources  such as  investments  by others in the  Company  and through
possible  transactions with strategic or joint venture partners.  We do not plan
to use any capital  raised for the purchase or sale of any plant or  significant
equipment.  The following  discussion and analysis should be read in conjunction
with  the  financial  statements  of the  Company  and  the  accompanying  notes
appearing subsequently under the caption "Financial Statements."

     Comparison of Operating Results for the Quarter Ended September 30, 2008 to
the Quarter Ended September 30, 2007

Revenues

     The Company did not  generate any revenues  from  operations  for the three
months ended  September 30, 2008 or 2007.  Accordingly,  comparisons  with prior
periods  are not  meaningful.  The  Company is subject to risks  inherent in the
establishment of a new business enterprise,  including limited capital resources
and cost increases in services.

Operating Expenses

     Operating  expenses  increased  $5,000 for the three months ended September
30, 2008 compared to the three months ended  September 30, 2008, from $16,500 to
$21,500. This increase was due to increase professional fees incurred.

Interest Expense

     Interest expense for the three months ended September 30, 2008 and 2007 was
$2,729  and  $4,297,  respectively.  The  decrease  was a result  of debt  being
converted into common stock.

Net Income/Loss

     Net loss  increased by $3,432 from net loss of $20,797 for the three months
ended  September  30, 2007 to a net loss of $24,229 for the three  months  ended
September  30,  2008.  The  increase in net  operating  loss is due to decreased
interest expense and increased professional fees.

     At September 30, 2008, our accumulated deficit was $1,462,822.

Assets and Liabilities

     Our total assets were $0 at September 30, 2008.

     Total Current  Liabilities  are $403,197 at September  30, 2008.  Our notes
payable and accrued interest are for $145,141.



                                       10
<PAGE>



Financial Condition, Liquidity and Capital Resources

     At September 30, 2008, we had cash and cash  equivalents of $0. Our working
capital is presently  minimal and there can be no assurance  that our  financial
condition  will  improve.  To  date,  we  have  not  generated  cash  flow  from
operations.

     As of September 30, 2008, we had a working capital deficit of $403,197. The
Company will seek funds from possible  strategic and joint venture  partners and
financing to cover any short term  operating  deficits and provide for long term
working capital.  No assurances can be given that the Company will  successfully
engage  strategic  or joint  venture  partners or  otherwise  obtain  sufficient
financing through the sale of equity.

     No trends have been identified which would materially  increase or decrease
our results of operations or liquidity.

     Comparison  of Operating  Results for the Nine Months Ended  September  30,
2008 to the Nine Months Ended September 30, 2007

Revenues

     The Company did not  generate  any revenues  from  operations  for the nine
months ended  September 30, 2008 or 2007.  Accordingly,  comparisons  with prior
periods  are not  meaningful.  The  Company is subject to risks  inherent in the
establishment of a new business enterprise,  including limited capital resources
and cost increases in services.

Operating Expenses

     Operating  expenses  increased  by $11,500 from $43,000 for the nine months
ended  September  30, 2007 to $54,500 for the nine months  ended  September  30,
2008.  The  increase  in  our  net  operating   expenses  is  due  to  increased
professional fees.

Interest Expense

     Interest  expense for the nine months ended September 30, 2008 and 2007 was
$9,295  and  $10,153,  respectively.  The  decrease  was a result of debt  being
converted into common stock.

Net Income/Loss

     Net loss  increased by $10,642 from net loss of $53,153 for the nine months
ended  September  30, 2007 to a net loss of $63,795  for the nine  months  ended
September 30, 2008.  The increase in net operating  loss is due to the increased
professional fees and G&A expenses incurred.

     At September 30, 2008, our accumulated deficit was $1,462,822.

Assets and Liabilities

     Our total assets were $0 at September 30, 2008.

     Total Current  Liabilities  are $403,197 at September  30, 2008.  Our notes
payable and accrued interest are for $145,141.

Financial Condition, Liquidity and Capital Resources

     At September 30, 2008, we had cash and cash  equivalents of $0. Our working
capital is presently  minimal and there can be no assurance  that our  financial
condition  will  improve.  To  date,  we  have  not  generated  cash  flow  from
operations.



                                       11
<PAGE>



     As of September 30, 2008, we had a working capital deficit of $403,197. The
Company will seek funds from possible  strategic and joint venture  partners and
financing to cover any short term  operating  deficits and provide for long term
working capital.  No assurances can be given that the Company will  successfully
engage  strategic  or joint  venture  partners or  otherwise  obtain  sufficient
financing through the sale of equity.

     No trends have been identified which would materially  increase or decrease
our results of operations or liquidity.

Plan of Operation

     The Company's  plan of operation  through  December 31, 2008 is to focus on
finding a suitable  merger  candidate or a viable  business plan. The Company is
seeking to raise capital to implement the Company's  business  strategy.  In the
event  additional  capital  is not  raised,  the  Company  may  seek  a  merger,
acquisition or outright sale.

Critical Accounting Policies

     Use of Estimates:  The  preparation  of financial  statements in conformity
with accounting  principles  generally  accepted in the United States of America
requires  management to make estimates and assumptions  that affect the reported
amounts  of assets and  liabilities  and  disclosure  of  contingent  assets and
liabilities at the date of the financial  statements and the reported amounts of
revenues and expenses during the reporting  period.  Actual results could differ
materially from those estimates.

     Loss per share:  Basic loss per share excludes  dilution and is computed by
dividing the loss  attributable to common  shareholders by the  weighted-average
number of common  shares  outstanding  for the  period.  Diluted  loss per share
reflects  the  potential  dilution  that  could  occur  if  securities  or other
contracts to issue common stock were exercised or converted into common stock or
resulted  in the  issuance of common  stock that  shared in the  earnings of the
Company.  Diluted loss per share is computed by dividing  the loss  available to
common  shareholders by the weighted average number of common shares outstanding
for  the  period  and  dilutive   potential  common  shares  outstanding  unless
consideration  of  such  dilutive   potential  common  shares  would  result  in
anti-dilution.  Common stock  equivalents were not considered in the calculation
of diluted loss per share as their effect would have been anti- dilutive for the
periods ended September 30, 2008 and 2007.

Going Concern.

     The Company has suffered recurring losses from operations and is in serious
need of  additional  financing.  These  factors  among others  indicate that the
Company may be unable to continue as a going concern,  particularly in the event
that it cannot  obtain  additional  financing or, in the  alternative,  affect a
merger or  acquisition.  The Company's  continuation  as a going concern depends
upon its ability to generate  sufficient cash flow to conduct its operations and
its  ability  to  obtain  additional  sources  of  capital  and  financing.  The
accompanying  financial  statements do not include any  adjustments  that may be
necessary if the Company is unable to continue as a going concern.


ITEM 3. Quantitative and Qualitative Disclosures About Market Risk

     The  Company is not  subject to any  specific  market  risk other than that
encountered by any other public company related to being publicly traded.



                                       12
<PAGE>



ITEM 4T. Controls and Procedures

     Our management,  which includes our Chief Executive Officer who also serves
as  our  principal  financial  officer,  have  conducted  an  evaluation  of the
effectiveness  of our  disclosure  controls and  procedures  (as defined in Rule
13a-14(c) promulgated under the Securities and Exchange Act of 1934, as amended)
as of a date (the "Evaluation Date") as of the end of the period covered by this
report.  Based upon that  evaluation,  our  management  has  concluded  that our
disclosure controls and procedures are effective for timely gathering, analyzing
and disclosing the  information we are required to disclose in our reports filed
under the  Securities  Exchange  Act of 1934,  as  amended.  There  have been no
significant changes made in our internal controls or in other factors that could
significantly  affect our internal controls  subsequent to the end of the period
covered by this report based on such evaluation.



                          PART II. - OTHER INFORMATION


ITEM 1.  Legal Proceedings

     The  Company  is a  defendant  in a civil  action  styled  Glen v.  Medical
Makeover  Corporation  of America,  et al, Case Number #  200594178H,  currently
pending in the  Circuit  Court of the Fifteen  Judicial  Circuit IN AND FOR Palm
Beach County,  Florida. The action was filed by a former employee of the company
asserting  claims against the Company  resulting  from his  discharge,  and also
includes  claims  that the  Company  took  certain  alleged  protected  business
concepts and practices  from him to and for the benefit of the Company,  for all
of which  he has  been  allegedly  damaged.  The  Company  and its  counsel  are
currently  defending this action and believe that the claims as made are without
merit and are defensible. The Company intends to vigorously defend these claims.


ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

     None.


ITEM 3. Defaults Upon Senior Securities

     None.


ITEM 4. Submission of Matters to a Vote of Security Holders

     None.


ITEM 5. Other Information

     None







                                       13
<PAGE>



ITEM 6. Exhibits and Reports

     (a) The following  sets forth those  exhibits filed pursuant to Item 601 of
Regulation S-K:

Exhibit
No.       Description
-------  ---------------------------------
31.1   *  Rule 13a-14(a)/ 15d-14(a) Certification of Chief Executive Officer

31.2   *  Rule  13a-14(a)/ 15d-14(a) Certification  of Principal  Financial  and
          Accounting Officer

32.1   *  Section 1350  Certification  of  Chief  Executive  Officer and   Chief
          Financial Officer,

------------
*    Filed herewith.


     (b) The following  sets forth the  Company's  reports on Form 8-K that have
been filed during the quarter for which this report is filed:

     None.



                                    SIGNATURE

     Pursuant  to the  requirements  of  Section  13 or 15(d) of the  Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.


                     Medical Makeover Corporation of America


                                     By:    /s/ Douglas P Martin
                                           ---------------------------
                                           Douglas P Martin
                                           Chief Executive Officer,
                                           President and Chairman of the Board*
Date: November 12, 2008


*    Douglas P Martin  has  signed  both on behalf of the  registrant  as a duly
     authorized officer and as the Registrant's principal accounting officer.










                                       14